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Background: Over the past two decades, initial disease out-
break reports were increasingly based on nontraditional sources
such as news media, online search queries, social media and par-
ticipatory systems. Strategically tapping into these resources can
help speed up detection, reporting and responses to new outbreaks
of emerging infectious diseases allowing earlier interventions.
The EpiCore Project – a joint venture between the Skoll Global
Threats Fund, HealthMap, ProMED-mail, and TEPHINET – seeks to
maximize the advantage of these nontraditional sources by cre-
ating a system for ﬁeld-based veriﬁcation of reports from these
sources. This system creates a cadre of trained health profession-
als from around the world and leverages their expertise to verify
reports they receive in their geographic proximity through innova-
tive surveillance approaches.
Methods & Materials: The EpiCore project developed a
specialized expert-led training that aims to highlight current dis-
ease surveillance challenges, demonstrate innovative surveillance
methods, explain their role in complementing traditional surveil-
lance, introduce different online sources for outbreak surveillance,
and allow the participants to assess challenges in current innova-
tive surveillance approaches before introducing the unique online
platform speciﬁcally developed by the EpiCore project to connect
health professionals to verify outbreak reports.
The EpiCore Project provided the training in two formats, online
– for accepted applicants to the project, and in-person, which was
conducted at 6 TEPHINETConferences, including theGlobal Confer-
ence and the regional conferences in Asia, Africa, the Middle East,
and Latin America over the past two years.
Results: 174 people attended a series of TEPHINET regional
workshops and provided feedback through surveys, interviews,
and focus groups. This feedback helped mold a specialized online
training that was necessary to reach global audiences, and fur-
ther understand the mechanism by which to recruit and engage
participants worldwide. Since the launch in October of 2015, 80%
accepted applicants successfully ﬁnished the online training and
were granted privileges to access the EpiCore platform where they
could start receiving and responding to requests for veriﬁcation of
disease outbreaks.
Conclusion: The EpiCore project’s training and online platform
are developing a cadre of trained health professionals to verify
reports of potential outbreaks from nontraditional sources, com-
plementing traditional surveillance, and contributing to ﬁnding
outbreaks faster.
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Background: Many treatment guidelines for Dengue prohibit
using Non-Steroidal Anti-inﬂammatory Drugs (NSAIDS). However,
these are still used either prescribed by general practitioners or
taken ‘over the counter’ by general public, for symptomatic relief.
Side effects of NSAIDs include hepatitis and increased bleeding.
But, there is no study evidence on howNSAIDS affects bleeding and
liver in Dengue infection.
Methods & Materials: A prospective Case Control Study was
conducted to determine the actual effect of NSAIDs on bleeding
and liver in Dengue. All patients admitted to Dengue Management
Unit at the Infectious Diseases Hospital, Colombo for four months
from 1st of July 2014 were included in the study. Dengue infection
was conﬁrmed byNS1 antigen or Dengue speciﬁc IgM antibodies. A
history of NSAID treatment prior to hospital admission was looked
for. These patients were followed up to see the development of
bleeding and/or hepatitis.
Results: Therewere 919 patients with conﬁrmed Dengue infec-
tion with 499 males and 420 females. Age ranged from 12 to 86
years. (mean 31 years.) 57.2% (n=526) had DF; 42.8% (n=393) had
DHF.
6.6% (n=65)were deﬁnitely treatedwithNSAIDs prior to admis-
sion, while 57% (n=577) have not used NSAIDs deﬁnitely; the
rest (35.6%) were not certain. Out of DF patients 28% developed
bleeding in the non-NSAIDS group while 36.7% had bleeding in the
NSAIDS group (<0.05). Among the DHF patients 34% had bleeding
in non-NSAIDS group while 51% had bleeding in the NSAIDS group
(p<0.05).
25.0% of the NSAIDs users and 14.8% of non-NSAIDS users had
ALT above300/L (p <0.05). 3.1%NSAIDSusers andnonon-NSAIDS
users had ALT greater than 1000 /L.
37.5% of NSAID group and 23.8% of non-NSAIDS group had AST
greater than 300 /L. (p <0.05). 6.2% of NSAIDS group and no non-
NSAIDS group had AST greater than 1000 /L.
Conclusion: There is signiﬁcant increase in bleeding and in
liver enzymederangement inDengue patients treatedwithNSAIDS
